Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-14
DOI
10.3389/fimmu.2020.564288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring and comparing adverse events between PARP inhibitors
- (2019) Christopher J LaFargue et al. LANCET ONCOLOGY
- Protective effect and mechanism of IL-10 on renal ischemia–reperfusion injury
- (2019) Kenji Sakai et al. LABORATORY INVESTIGATION
- Regulated necrosis in kidney ischemia-reperfusion injury
- (2019) Aspasia Pefanis et al. KIDNEY INTERNATIONAL
- OPTN/SRTR 2017 Annual Data Report: Kidney
- (2019) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke
- (2018) Youngchul Kim et al. MOLECULAR NEUROBIOLOGY
- Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond
- (2018) Hailin Zhao et al. EBioMedicine
- Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells
- (2018) Stephanie F. Smith et al. KIDNEY INTERNATIONAL
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immune cells in experimental acute kidney injury
- (2014) Hye Ryoun Jang et al. Nature Reviews Nephrology
- PARP-1 Hyperactivation and Reciprocal Elevations in Intracellular Ca2+ During ROS-Induced Nonapoptotic Cell Death
- (2014) Fengjiao Zhang et al. TOXICOLOGICAL SCIENCES
- PARP Inhibition Attenuates Histopathological Lesion in Ischemia/Reperfusion Renal Mouse Model after Cold Prolonged Ischemia
- (2013) Raimundo M. G. del Moral et al. TheScientificWorldJOURNAL
- Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research
- (2012) C. Kilkenny et al. OSTEOARTHRITIS AND CARTILAGE
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
- (2010) Raga Krishnakumar et al. MOLECULAR CELL
- PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion
- (2009) David H. Stone et al. AMERICAN JOURNAL OF SURGERY
- PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases
- (2009) Andreína Peralta-Leal et al. FREE RADICAL BIOLOGY AND MEDICINE
- VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury
- (2009) Florian Tögel et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The interaction between ischemia–reperfusion and immune responses in the kidney
- (2009) Hye Ryoun Jang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- 3-Aminobenzamide, a Poly ADP Ribose Polymerase Inhibitor, Attenuates Renal Ischemia/Reperfusion Injury
- (2009) Emin Oztas et al. RENAL FAILURE
- Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
- (2008) Pal Pacher et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started